Nivolumab,Relatlimab
BMS
['lcsm,(-blcsm)']
#asco23 : study presents data on preoperative lag-3 inhibition #lcsm. all pts operated within 43 days of treatment initiation . 95% achieved r0 resection . no significant differences in complications or outcomes between groups 
Fellow @MayoHemeOnc | @UConnIM| @UTexasSPH| @MDAndersonNews|@COVID19nCCC| #SoMeEditor @JCOCCI_ASCO| Co-Host @HemOncFellows @LungCancerRX https://t.co/dsiuV460lQ